Market
Home Market Community Pricing

Welcome to TradeProwl

Sign in to access your dashboard, portfolio tracking, and real-time alerts.

MDT

Medtronic plc.Healthcare | Medical Devices
$96.54 -0.57 -0.59% Checking... ---
5m
---
Day Range
$96.46
$98.09
52-Week Range
$73.31
$106.33
Upcoming Earnings
--- ---

Medtronic plc develops, manufactures, and sells device-based medical therapies to healthcare systems, physicians, clinicians, and patients in the United States, Ireland, and internationally. It operates through three segments: The Cardiovascular Portfolio, Neuroscience Portfolio, and Medical Surgical Portfolio. The Cardiovascular Portfolio segment offers implantable cardiac pacemakers, cardioverter defibrillators, and cardiac resynchronization therapy devices; cardiac ablation products; insertable cardiac monitor systems; TYRX products; and remote monitoring and patient-centered software. It also provides aortic valves, surgical valve replacement and repair products, endovascular stent grafts and accessories, and transcatheter pulmonary valves, left atrial appendage exclusion systems, extracorporeal membrane oxygenation (ECMO) systems and percutaneous coronary intervention products, percutaneous angioplasty balloons, and endovenous products. The Neuroscience Portfolio segment offers medical devices and implants, biologic solutions, spinal cord stimulation and brain modulation systems, implantable drug infusion systems, and interventional products, as well as nerve ablation system under the Accurian name. This segment offers its products for spinal surgeons, neurosurgeons, neurologists, pain management specialists, anesthesiologists, orthopedic surgeons, urologists, urogynecologists, and interventional radiologists, as well as ear, nose, and throat specialists, and energy surgical instruments. The Medical Surgical Portfolio segment offers surgical stapling devices, vessel sealing instruments, wound closure and electrosurgery products, AI-powered surgical video and analytics platform, robotic-assisted surgery products, hernia mechanical devices, mesh implants, gynecology products, gastrointestinal and hepatologic diagnostics and therapies, and therapies to treat diseases and conditions, and patient monitoring and airway management products, as well as insulin pumps and consumables, continuous glucose monitoring systems, and sensors. Medtronic plc was founded in 1949 and is headquartered in Galway, Ireland.

Congress
  • Kevin HernR-OK · House · Aug 24, 2026 Sell$15,001 - $50,000
  • Richard Dean Dr McCormickR-GA · House · Jul 30, 2026 Sell$1,001 - $15,000
  • Gilbert CisnerosD-CA · House · May 15, 2026 Sell$1,001 - $15,000
Corporate insiders
  • Martha GeoffreyDirector, Chairman and CEO · Oct 16, 2026 Sell$4.75M
  • Marinaro MichaelEVP, Pres MedSurg and Americas · Oct 16, 2026 Sell$1.00M
  • KIIL HARRY SKIPEVP & President Cardiovascular · Sep 17, 2026 Sell$138,882

From public Form 4 and STOCK Act filings.

123.49B
Market Cap
-
Forward P/E
23.72
Trailing P/E
-
Price/Book
-
EPS (TTM)
-
Revenue (TTM)
-
EBITDA
-
Free CF
-
Total Debt
-
Beta
-
Gross Margin
-
Op. Margin
-
Div Rate
-
Div Yield
-
Ex-Div Date
-
Sector
-
Industry
-
Short % Float

Unusual Whale Flow

Loading anomaly scanner...

Alert